These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7219341)

  • 1. [Treatment of hyperuricemia].
    Sailer D
    Med Klin; 1981 Feb; 76(5):142-3. PubMed ID: 7219341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
    Arntz HR; Dreykluft HR; Leonhardt H
    Fortschr Med; 1979 Jul; 97(27):1212-4. PubMed ID: 457017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F
    Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP
    Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolated or combined drug therapy of hyperuricemia?].
    Mertz DP
    Dtsch Med Wochenschr; 1977 Jul; 102(30):1096-7. PubMed ID: 891391
    [No Abstract]   [Full Text] [Related]  

  • 7. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP
    MMW Munch Med Wochenschr; 1978 Oct; 120(42):1387-90. PubMed ID: 101792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of hyperuricemia after kidney transplantation].
    Flury W; Ruch HR; Montandon A
    Schweiz Med Wochenschr; 1977 Sep; 107(38):1339-41. PubMed ID: 335500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 10. [The correction of hyperuricemia in patients with different forms of nephrolithiasis using allopurinol and Allomaron].
    Darenkov AF; Konstantinova OV; Ianenko EK
    Urol Nefrol (Mosk); 1994; (5):35-7. PubMed ID: 7871619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
    Matzkies F
    Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
    Fortschr Med; 1979 May; 97(17):835-6. PubMed ID: 437646
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W; Walter-Sack I; de Vries JX
    Eur J Med Res; 1998 Feb; 3(1-2):77-80. PubMed ID: 9512972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzbromarone therapy in hyperuricaemia; comparison with allopurinol and probenecid.
    Schepers GW
    J Int Med Res; 1981; 9(6):511-5. PubMed ID: 7033016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].
    Mertz DP; Borner K
    Med Welt; 1983 Sep; 34(36):974-9. PubMed ID: 6633222
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of hyperuricemia in diabetes].
    Hirai A; Saito Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():781-5. PubMed ID: 9434564
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic effectiveness of the combination allopurinol-benziodarone in the treatment of hyperuricemia].
    Pecora P; Suraci C; Dessì R; De Maria S; Assisi A
    Clin Ter; 1982 Mar; 100(5):463-76. PubMed ID: 6982797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.